REVIEW
|
doi:10.20944/preprints202311.1079.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
neuroblastoma; high-risk; retinoids; retinoic acids; isotretinoin; retinoid therapy; tumor differentiation therapy; maintenance therapy; off-label issue
Online: 16 November 2023 (11:37:03 CET)